0000897069-24-001475.txt : 20240702
0000897069-24-001475.hdr.sgml : 20240702
20240702162034
ACCESSION NUMBER: 0000897069-24-001475
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240630
FILED AS OF DATE: 20240702
DATE AS OF CHANGE: 20240702
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Quaggin Susan E
CENTRAL INDEX KEY: 0001997505
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35565
FILM NUMBER: 241095647
MAIL ADDRESS:
STREET 1: 1 NORTH WAUKEGAN ROAD
CITY: NORTH CHICAGO
STATE: IL
ZIP: 60064
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AbbVie Inc.
CENTRAL INDEX KEY: 0001551152
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 320375147
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1 NORTH WAUKEGAN ROAD
CITY: NORTH CHICAGO
STATE: IL
ZIP: 60064
BUSINESS PHONE: (847) 932-7900
MAIL ADDRESS:
STREET 1: 1 NORTH WAUKEGAN ROAD
CITY: NORTH CHICAGO
STATE: IL
ZIP: 60064
4
1
form4.xml
X0508
4
2024-06-30
0001551152
AbbVie Inc.
ABBV
0001997505
Quaggin Susan E
1 N. WAUKEGAN ROAD
NORTH CHICAGO
IL
60064
true
false
Stock Equivalent Units
171.52
2024-06-30
4
A
0
87
171.52
A
Common Stock
87
236
D
Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock.
Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.
/s/ T.O. Odutayo, Attorney-in-Fact for Susan E. Quaggin
2024-07-02